Celligent? isn’t just an automated cell culture system; it’s a continually improving platform. With every use, it becomes smarter, handling complex tasks like cell selection, imaging, and tracking with unmatched precision and efficiency. Celligent? simplifies processes, reduces variability, and ensures consistent, high-quality results, supporting researchers in delivering groundbreaking results more efficiently than ever. Discover the future of cell processing: https://lnkd.in/ekwVpUTT #celltherapy #cellprocessing #pharma #biotech #video
Cell X Technologies
生物技术研究
Cleveland,Ohio 1,029 位关注者
Automated Imaging and Selection for Stem Cell Research and Cell Manufacturing
关于我们
Cell X is pioneering a revolution in cell processing. At the core of this revolution lies our transformative Celligent platform – an innovative bundling of automation, imaging, data analytics, and machine learning that enables therapeutic researchers to develop consistent, reproducible, and scalable GMP-compliant processes for stem cells and bio-fabrication. Celligent enables the development of safe and effective products by executing the necessary process development and cell manufacturing procedures in a fully documented, compliant way. Successful cellular therapies demand starting with optimized cell sources; and intrinsic variability and heterogeneity among cell sources presents a major challenge. This critical first step of control over starting materials demands the use of quantitative and reproducible standards for cell and clone selection and process management based on critical process parameters (CPPs) in order to achieve products with defined critical quality attributes (CQAs). Backed by a highly experienced team, Cell X automates cell processing in diverse cell culture applications spanning mesenchymal stromal/stem cells (MSCs) and exosomes, induced pluripotent stem cells (iPSCs), hematopoietic stem cells (HSCs), connective tissue progenitor cells (CTPs) and tumor-infiltrating lymphocytes (TILs) as well as other progenitor cell types. We are dedicated to advancing the promise of cellular therapies for innovators and patients alike, ultimately making cell therapies more accessible to millions of patients worldwide.?
- 网站
-
https://www.cellxtechnologies.com
Cell X Technologies的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Cleveland,Ohio
- 类型
- 私人持股
- 创立
- 2019
- 领域
- Cell Culture、Stem Cells、Regenerative Medicine、Biomedical Engineering、Bioengineering、Biotechnology、Cell Biology、Cell Imaging、Microscopy、Tissue Culture、Tissue Engineering、Mammalian Cell Culture、Medical Devices、Research、Life Sciences、Bioinformatics、Adult Stem Cells、Biopharmaceuticals、Induced Pluripotent Stem Cells、Mesenchymal Stem Cells、Drug Screening和Image Analysis
地点
-
主要
10000 Cedar Ave
US,Ohio,Cleveland,44106
Cell X Technologies员工
动态
-
Celligent? isn’t just an automated cell culture system; it’s a continually improving platform. With every use, it becomes smarter, handling complex tasks like cell selection, imaging, and tracking with unmatched precision and efficiency. Celligent? simplifies processes, reduces variability, and ensures consistent, high-quality results, supporting researchers in delivering groundbreaking results more efficiently than ever. Discover the future of cell processing: https://lnkd.in/ekwVpUTT #celltherapy #cellprocessing #pharma #biotech #video
-
Our Celligent? platform is more than a robotic cell processing system; it is revolutionizing cell processing and facilitating regulatory compliance. An integral aspect of this innovation is its data collection capabilities. Advanced Data Management: Celligent? streamlines the data collection process by automating the storage and tracking of critical data. This includes detailed imaging/morphometric data and comprehensive biopsied physiological and molecular information, all while maintaining 21 CFR Part 11 compliance. Regulatory Compliance Made Easy: With Celligent?, preparing for a successful regulatory filing is simpler and more reliable. The platform ensures that all necessary data is compliantly collected and easily accessible. Want to learn more about how Celligent can transform your cell processing? Visit us: https://lnkd.in/ekwVpUTT #celltherapy #cellprocessing #data #pharma #biotech
-
Our Celligent? platform is at the forefront of transforming cell processing, continuously advancing with every new challenge it encounters. Advanced Algorithms: Driven by machine learning, Celligent? incorporates proprietary algorithms to deliver cutting-edge performance, supporting researchers in achieving groundbreaking results. Evolving Intelligence: The Celligent? system isn’t just a tool—it’s a dynamically evolving platform. With each program, it becomes smarter, expanding its capabilities to ensure unparalleled precision and efficiency in automated cell processing. CxKnowledge Data Bank: At the core of our platform is the CxKnowledge data bank, a rich repository of annotated data. This invaluable resource empowers researchers and scientists with deep insights, fueling further innovation and discovery. Guiding Innovation: Leveraging the wealth of information in the CxKnowledge data bank, Celligent? enhances the Design of Experiments approach, streamlining research processes and maximizing efficiency. Explore Celligent?: https://lnkd.in/ekwVpUTT #celltherapy #machinelearning #ai #artificialintelligence #cellprocessing #pharma
-
Cell X Technologies is leading the way in cell processing innovation with our advanced Celligent? platform. At the core of every cell culture process lies a series of essential, non-negotiable steps that must be executed with unwavering consistency and precision— this is where Celligent? shines, redefining cell handling and selection to optimize for safety, efficacy, and success. Our Celligent? system goes beyond traditional automation, offering a comprehensive array of features that cover every aspect of cell culture, from sample preparation to automated customized decision-making, to culture maintenance. Designed for precision, the platform consistently delivers reproducible results, minimizing human error and reducing the risk of contamination. Embark on a journey towards more efficient and reliable cell culture processes with us. Learn how: https://lnkd.in/ekwVpUTT #celltherapy #automation #cellprocessing #pharma
-
“There are a number of universities and companies that are working to develop cell therapeutics. The problem that they have is their processes are all manual. By automating those steps, it makes them much more repeatable and much more reproducible.” Our Celligent? platform represents a pivotal step toward making cell therapies more accessible to patients. See more in our video. Explore Cell X Technologies: https://lnkd.in/ekwVpUTT Innovation Works | Lynne Frick | Brian C. Handerhan #celltherapy #stemcells #biopharma #advancedtherapies
-
We're thrilled to share a transformative piece penned by our own VP of Science and Technology, Karen Weisinger. In this article, Dr. Weisinger explores the challenges hindering the evolution and potential of both autologous and allogeneic cell therapies. With new technologies emerging continuously, it's crucial to consistently reassess how we can harness these innovations to re-address existing bottlenecks for the development of bold, life-saving treatments. Key Takeaways: * The unique challenges in manufacturing living therapies, from cell isolation to cultivation. * The significance of achieving process robustness and leveraging cutting-edge technologies. * A closer look at how our Celligent? platform is pioneering automation in cell processing to tackle these challenges head-on. With advancements like Celligent?, we're not just automating processes; we're setting new standards for quality and consistency in cell therapy manufacturing. Read the full article here: https://lnkd.in/eG2_TV9u #celltherapy #stemcells #pharma #biotech
-
Happy Memorial Day from all of us at Cell X Technologies! #memorialday #mdw #holiday #holidays
-
Celligent is reshaping the landscape of cell processing. It's not just a platform; it's a game-changer! Celligent takes high-resolution, large field of view images of iPSC colonies and automatically segments them, pinpointing precise pick locations. But why is this such a monumental advancement? It means we can now delve into iPSC morphology within early-phase reprogramming and establish critical links to downstream cell product quality. At Cell X Technologies, we're dedicated to pushing the boundaries of cell culture technology. Exciting updates are on the horizon, so stay tuned! In the meantime, visit our website to explore the endless possibilities of our revolutionary Celligent platform. Learn more: https://lnkd.in/ekwVpUTT #stemcells #celltherapy #cellprocessing #automation #biotech #digitaltransformation #science #pharmaceuticalindustry #lifesciences
Home - Cell X Technologies
https://cellxtechnologies.com
-
Today, we are thrilled to announce that Brian C. Handerhan has been promoted to the role of Chief Operating Officer at Cell X Technologies. As we continue our journey of innovation, Brian plays a pivotal role in overseeing the company's operations, product development, and product management to drive growth across our product and service offerings. Brian's career spans over 20 years in manufacturing engineer and advanced automation. Leveraging his experience, he has brought a wealth of leadership and operational experience to our team. His strong record industrial automation, manufacturing strategy and operations, product planning and supply chain optimization are critical to helping us meet the evolving demands of the cell therapy space. Meet the rest of the Cell X team: https://lnkd.in/ekwVpUTT #stemcells #celltherapy #automation #ai #platform #pharma #biotech #digitaltransformation #science #pharma #pharmaceuticalindustry #lifesciences
Home - Cell X Technologies
https://cellxtechnologies.com